Related references
Note: Only part of the references are listed.Circulating matrix metalloproteinases and their inhibitors in hypertension
Vanessa Fontana et al.
CLINICA CHIMICA ACTA (2012)
Elastin Degradation Is Associated With Progressive Aortic Stiffening and All-Cause Mortality in Predialysis Chronic Kidney Disease
Edward R. Smith et al.
HYPERTENSION (2012)
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis
Chiara Marchesi et al.
JOURNAL OF HYPERTENSION (2012)
Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension
Carla S. Ceron et al.
MATRIX BIOLOGY (2012)
Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target
Vanessa Fontana et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation
Anna Solini et al.
JOURNAL OF HYPERTENSION (2011)
Role of extracellular matrix in vascular remodeling of hypertension
Ana M. Briones et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways
W. C. Burns et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Cellular mediators of renal vascular dysfunction in hypertension
Bharathy Ponnuchamy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
Matrix Metalloproteinases: Discrete Elevations in Essential Hypertension and Hypertensive End-Stage Renal Disease
Ryan S. Friese et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2009)
The macrocirculation and microcirculation of hypertension
Francois Feihl et al.
CURRENT HYPERTENSION REPORTS (2009)
Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment
Ibrahim Koral Onal et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Kidney fibrosis in hypertensive rats: Role of oxidative stress
Wenyuan Zhao et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction
A. W. Chung et al.
JOURNAL OF VASCULAR RESEARCH (2008)
Role of matrix metalloproteinases in renal pathophysiologies
J. M. Catania et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Matrix metalloproteinases in peripheral vascular disease
Mark J. Hobeika et al.
JOURNAL OF VASCULAR SURGERY (2007)
An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy
Sang Youb Han et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury
Sunfa Cheng et al.
FASEB JOURNAL (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Elastic fibres and vascular structure in hypertension
Silvia M. Arribas et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats
MY Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells
LJ Min et al.
CIRCULATION RESEARCH (2005)
Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients
A Ergul et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metal loproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP
MM Bernardo et al.
BIOCHEMICAL JOURNAL (2003)
Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats
TM Camp et al.
JOURNAL OF HYPERTENSION (2003)
Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions
MP Jacob
BIOMEDICINE & PHARMACOTHERAPY (2003)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
Regression of renal vascular and glomerular fibrosis: Role of angiotensin II receptor antagonism and matrix metalloproteinases
JJ Boffa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after anti hypertensive treatment
A Zervoudaki et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway
PL Tharaux et al.
HYPERTENSION (2000)
Share Paper
